Bernd Löwe1, Kurt Kroenke, Kerstin Gräfe. 1. Department of General Internal and Psychosomatic Medicine, University of Heidelberg Medical Center, Im Neuenheimer Feld 410, Heidelberg D-69120, Heidelberg, Germany. bernd.loewe@med.uni-heidelberg.de
Abstract
OBJECTIVE: This study evaluates the two-item Patient Health Questionnaire (PHQ-2) as a measure for diagnosing and monitoring depression. METHODS: We assessed construct validity in a cross-sectional sample of 1619 medical outpatients (mean age 43+/-14 years, 64% female) by comparing the PHQ-2 to four longer self-report questionnaires. Criterion validity was established in a subsample of 520 participants with reference to the Structured Clinical Interview for DSM-IV (SCID). Sensitivity to change was investigated in a prospective study of 167 patients who completed the SCID both at baseline and the 1-year follow-up. RESULTS: With reference to the SCID, the PHQ-2 had a sensitivity of 87% and a specificity of 78% for major depressive disorder and a sensitivity of 79% and a specificity of 86% for any depressive disorder. Its diagnostic performance was comparable with that of longer depression scales. PHQ-2 change scores accurately reflected improved, unchanged, and deteriorated depression outcomes. CONCLUSION: The PHQ-2 performed favorably with respect to a standard diagnostic interview, as well as established depression scales and proved sensitive to change. Thus, the PHQ-2 appears promising as a brief multipurpose measure for detecting depression, grading its severity, and monitoring outcomes over time.
OBJECTIVE: This study evaluates the two-item Patient Health Questionnaire (PHQ-2) as a measure for diagnosing and monitoring depression. METHODS: We assessed construct validity in a cross-sectional sample of 1619 medical outpatients (mean age 43+/-14 years, 64% female) by comparing the PHQ-2 to four longer self-report questionnaires. Criterion validity was established in a subsample of 520 participants with reference to the Structured Clinical Interview for DSM-IV (SCID). Sensitivity to change was investigated in a prospective study of 167 patients who completed the SCID both at baseline and the 1-year follow-up. RESULTS: With reference to the SCID, the PHQ-2 had a sensitivity of 87% and a specificity of 78% for major depressive disorder and a sensitivity of 79% and a specificity of 86% for any depressive disorder. Its diagnostic performance was comparable with that of longer depression scales. PHQ-2 change scores accurately reflected improved, unchanged, and deteriorated depression outcomes. CONCLUSION: The PHQ-2 performed favorably with respect to a standard diagnostic interview, as well as established depression scales and proved sensitive to change. Thus, the PHQ-2 appears promising as a brief multipurpose measure for detecting depression, grading its severity, and monitoring outcomes over time.
Authors: Seong-Yi Baik; Junius J Gonzales; Barbara J Bowers; Jean S Anthony; Bas Tidjani; Jeffrey L Susman Journal: Ann Fam Med Date: 2010 May-Jun Impact factor: 5.166
Authors: Andrew H Rogers; Michael F Orr; Justin M Shepherd; Jafar Bakhshaie; Joseph W Ditre; Julia D Buckner; Michael J Zvolensky Journal: J Behav Med Date: 2020-06-27
Authors: Trina E Chang; Charlotte D Brill; Lara Traeger; C Andres Bedoya; Aya Inamori; Patrick N Hagan; Katherine Flaherty; Katherine Hails; Albert Yeung; Nhi-Ha Trinh Journal: J Immigr Minor Health Date: 2015-12
Authors: Adam G Horwitz; Johnny Berona; Danielle R Busby; Daniel Eisenberg; Kai Zheng; Jacqueline Pistorello; Ronald Albucher; William Coryell; Todd Favorite; Joseph C Walloch; Cheryl A King Journal: Suicide Life Threat Behav Date: 2020-04-15
Authors: Arjan G J Bot; Stijn Bekkers; Paul M Arnstein; R Malcolm Smith; David Ring Journal: Clin Orthop Relat Res Date: 2014-04-29 Impact factor: 4.176
Authors: R Christopher Sheldrick; Brandi S Henson; Emily N Neger; Shela Merchant; J Michael Murphy; Ellen C Perrin Journal: Acad Pediatr Date: 2012-10-23 Impact factor: 3.107